CDEK
← All organizations

Biospecifics Technologies Corp.

For profitContributed to NMEWebsite ↗

Also known as: Advance Biofactures | ADVANCE BIOFACTURES | Advance Biofactures Corporation

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 3

First clinical trial

Jun 1, 2003

First marketed drug

Jun 4, 1965

Last known activity

Sep 1, 2016

Acquired by Endo Pharmaceuticals → Mallinckrodt (2013) on Oct 19, 2020

Timeline

1950s

  1. Jan 1, 1957

    Biospecifics Technologies Corp.— Founded

1960s

  1. Jun 4, 1965

    collagenase clostridium histolyticum— Marketing Organization

2020s

  1. Oct 19, 2020

    Endo Pharmaceuticals— Acquired By

  2. Mar 1, 2025

    Mallinckrodt (2013)— Now

Drugs by trial phase (2 distinct, 5 trials)

Phase 3 (1 own, 0 via acquisition)

Phase 1 (1 own, 0 via acquisition)

Indications

Studied for

Marketed drugs (1)

Recent trials (5)

Details

Founded
Lynbrook, NY, US Jan 1, 1957
Last known activity
Sep 1, 2016